Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 28, 2005; 11(8): 1141-1148
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1141
Figure 1
Figure 1 Serum ALT and AST levels in the CCl4- or CCl4 with silymarin-treated groups. A: Serum ALT levels were detected at 4, 8, and 12 wk; B: Serum AST levels were detected at 4, 8, and 12 wk. In the CCl4 with silymarin-treated group (black bar), increase of serum ALT and AST levels were lower than those of CCl4-treated group (open bar).